Kay Murphy
3Patents
3h-index
7Co-inventors
39Inventor score
Filing activity: Jun 6, 1995 → Oct 3, 2001
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5783181A | Therapeutic uses of fusion proteins between mutant IL 4/IL13 antagonists and immunoglobulins | Chemistry; Metallurgy | 69 | Expired |
| US6319689A | ASP2 | Human Necessities | 48 | Expired |
| US6870030B2 | ASP2 | Human Necessities | 19 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.